- Home
- FFA vs COO Comparison
FFA vs COO Comparison
Compare FFA & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FFA
- COO
- Stock Information
- Founded
- FFA 2004
- COO 1980
- Country
- FFA United States
- COO United States
- Employees
- FFA N/A
- COO 16000
- Industry
- FFA Investment Managers
- COO Ophthalmic Goods
- Sector
- FFA Finance
- COO Health Care
- Exchange
- FFA Nasdaq
- COO Nasdaq
- Market Cap
- FFA 409.4M
- COO 14.6B
- IPO Year
- FFA N/A
- COO N/A
- Fundamental
- Price
- FFA $20.73
- COO $74.77
- Analyst Decision
- FFA
- COO Strong Buy
- Analyst Count
- FFA 0
- COO 9
- Target Price
- FFA N/A
- COO $99.67
- AVG Volume (30 Days)
- FFA 26.1K
- COO 2.9M
- Earning Date
- FFA 01-01-0001
- COO 08-27-2025
- Dividend Yield
- FFA 6.72%
- COO N/A
- EPS Growth
- FFA N/A
- COO 21.77
- EPS
- FFA N/A
- COO 2.07
- Revenue
- FFA N/A
- COO $3,988,200,000.00
- Revenue This Year
- FFA N/A
- COO $6.79
- Revenue Next Year
- FFA N/A
- COO $6.44
- P/E Ratio
- FFA N/A
- COO $36.12
- Revenue Growth
- FFA N/A
- COO 6.88
- 52 Week Low
- FFA $15.84
- COO $65.00
- 52 Week High
- FFA $19.30
- COO $112.38
- Technical
- Relative Strength Index (RSI)
- FFA 73.24
- COO 55.66
- Support Level
- FFA $20.50
- COO $69.01
- Resistance Level
- FFA $20.76
- COO $77.06
- Average True Range (ATR)
- FFA 0.19
- COO 1.65
- MACD
- FFA 0.03
- COO 0.85
- Stochastic Oscillator
- FFA 96.03
- COO 74.38
About FFA First Trust Enhanced Equity Income Fund
First Trust Enhanced Equity Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide high level of current income and gains and, to a lesser extent, capital appreciation. The Fund pursues its investment objective by investing in a diversified portfolio of equity securities.
About COO The Cooper Companies Inc.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.